Thymic stromal lymphopoietin (TSLP) is a novel IL-7-like hematopoietic cytokine. Human TSLP is produced by epithelial cells, stromal cells, and mast cells. The TSLP gene is highly expressed in synovial fluid specimens derived from rheumatoid arthritis (RA) patients. We previously identified four single nucleotide polymorphisms (SNPs) and one variation site in human TSLP gene. In this study, we analyzed the genotypic and allelic frequencies of the TSLP SNPs between RA patients and healthy controls. We also investigated the relationships between SNP genotypes and the RF levels and anti-synthetic cyclic citrullinated peptide (CCP) levels in RA patients. We then calculated the haplotype frequencies defined by these SNPs for both groups. The genotype and allele frequencies of the TSLP SNPs did not differ significantly between the RA patients and the healthy controls. We also found that TSLP SNPs in the RA patients had no significant association with the levels of RF or anti-CCP. Our results suggest that TSLP SNPs are not associated with susceptibility to RA.
Introduction
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, and is arisen by the complex interaction between multiple genetic factors and environmental factors [7] . A characteristic feature of RA is the presence of rheumatoid factors (RFs) and RF-containing immune complexes in both the circulation and synovial fluid [6] . RFs are auto-antibodies that recognize the Fc region of immunoglobulin G (IgG) antibodies and their isotypes. RF has been widely used as a screening test for patients with arthritis. RF is prognostically useful to correlates with functional [17] and outcomes in both RA and early inflammatory polyarthritis [8] . A highly specific autoantibody system has been described for RA, in which the synthetic cyclic citrullinated peptide (CCP) with deiminated arginines is used as the antigen for the anti-CCP antibodies [15] . Anti-CCP antibodies are locally present at the site of inflammation in RA [14] , and citrullinated proteins are found in the RA synovium [2] .
Thymic stromal lymphopoietin (TSLP) gene product was proposed to signal through a heterodimeric receptor complex composed of the TSLP receptor (TSLPR) and the IL-7R alpha chain [12, 13] . Human TSLP is involved in dendritic cell maturation [16, 18] . The TSLP strongly activates CD11 + dendritic cells (DCs) and induces production of the Th2-attracting chemokines TARC (thymus and activation-regulated chemokine; also known as CCL-17) and MDC (macrophage-derived chemokine; CCL-22) [16] . TSLP-activated DCs prime CD4 + T helper cells produce proallergic cytokines IL-4, IL-5, IL-13, and tumor necrosis factor-α (TNF-α), while down-regulating IL-10 and IFN-γ. TSLP is highly expressed in bronchial epithelium and submucosa in allergic asthma [19] , and also expressed in synovial fluid specimens derived from RA patients [10] . These results suggest that TSLP might be involved in allergic diseases as well as in inflammatory arthritis such as RA. We previously identified four single nucleotide polymorphisms (SNPs) and one variation site in human TSLP gene, and showed that the TSLP SNPs are associated with susceptibility to allergic rhinitis [20] .
To determine whether the TSLP SNPs are associated with the susceptibility to RA, we analyzed the genotypic and allelic frequencies of the TSLP SNPs on genomic DNA samples isolated from the RA patients and the healthy controls. We further investigated the relationships between the genotypes of SNPs and the RF levels and anti-CCP levels in the RA patients. Finally, we calculated the haplotype frequencies defined by these SNPs in both groups.
Materials and Methods
Patients and DNA samples
The DNA samples used in this study were provided by the Biobank of Wonkwang University Hospital, which is a member of the National Biobank of Korea and this Biobank is supported by the Ministry of Health and Welfare Affairs.
On the basis of approval and informed consent from the institutional review board, we obtained the genomic DNAs from 457 RA patients and 568 healthy controls. The clinical parameter of the study subjects is summarized in Table 1 .
Genomic DNA was extracted from the leukocytes in the peripheral blood by a standard phenol-chloroform method or by using a Genomic DNA Extraction kit (iNtRON Biotechnology, Korea) according to the manufacturer's directions. RA was diagnosed according to the criteria of the American Rheumatism Association [1] . Anti-CCP level in the RA patients was determined by enzyme-linked immunosorbent assay (ELISA) using DIASTAT anti-CCP kit (MBL Co, Nagoya, Japan) and read by automated EIA analyzer, CODA (Bio-RAD Co, Japan). Anti-CCP antibody was considered positive when the absorbance was higher than the cut-off value (5U/ml). The concentration of anti-CCP antibody was estimated by interpolation from a dose-response curve based on standards. RF level in the RA patients was measured by the latex fixation test using Hitachi 7170S
(Hitachi Co, Tokyo, Japan). The cutoff for positivity was 18 IU/ml for RF. Healthy controls were recruited from the general population, and had received comprehensive medical testing at the Wonkwang University Hospital. All subjects in this study were Korean.
Genotype analysis
Genotype analysis of the TSLP SNPs, g.-1914A>G (rs3806932), g.-847C>T (rs3806933), g.-82C>T (rs2289276) and g.1117C>T, was performed by high resolution melting (HRM) analysis, as previously described [20] .
Statistic analysis
The RA patients and healthy control groups were compared using case-control association analysis. Logistic regression analyses (SPSS 11.5) were used to calculate the odds ratios (with the 95% confidence intervals). The
ANOVA method was applied to define the RF and anti-CCP levels of each genotype from the individual RA patients, and followed by Scheffe test for the after-verification. A P-value of less than 0.05 was considered to indicate statistical significance.
Results
The genotype frequencies of all loci were in HWE (p>0.05, data not shown). Although the genotype and allele frequency of g.-847C>T in RA patients was somewhat different from those of healthy controls group (p=0.066 and 0.035, respectively), the genotype and allele frequencies of the g.-1914A>G, g.-82C>T and g.1117C>T SNPs were not significantly different between the RA patients and healthy controls (Table 2) . We further analyzed the genotype and allele frequencies between the females of the control group and the RA patients because the RA patients were predominantly female compared with the healthy control subjects.
The genotype and allele frequencies of the TSLP SNPs were not significantly different between the female of the RA patients and the healthy controls (Table 3) . These results suggest that the SNPs of the TSLP gene could not be associated with the susceptibility to RA (Table 2, 3 ).
We also found that TSLP SNPs in the RA patients have no significant association with the levels of RF and anti-CCP (Table 4) .
Finally, we estimated the haplotype frequencies of the g.-1914A>G, g.-847C>T, g.-82C>T and g.1117C>T polymorphisms of TSLP gene between the healthy controls and the RA patients (Table 5) . Although the minor haplotypes (ATCC and ATTT) were significantly different in RA pa- tients as compared to those of the healthy controls (p=0.001 and 0.004, respectively), the distributions of major haplotypes, ACCC, GTTT and GTCC were not significant difference between the RA patients and the healthy controls (Table 5 ). These results suggest that the haplotypes of the TSLP polymorphisms are not associated with RA susceptibility.
Discussion
RA is one of the representative autoimmune diseases worldwide, and is characterized by inflammation of synovial tissues and the formation of rheumatoid pannus, which is capable of eroding adjacent cartilage and bone and causing subsequent joint destruction. We previously suggested that the exon 4 variations of the Tim-1 gene [3] , the eotaxin-3 polymorphisms [5] , and TBX21 polymorphisms [4] are associated with RA susceptibility.
TSLP is critical in the development and maintenance of atopic allergic disease as a master switch for allergic inflammation at the epithelial cell-DC interaction [9, 11] . TSLP is highly expressed in the keratinocytes of skin lesions of the atopic dermatitis patients and is associated with DCs activation [16] . The expression level of TSLP is also induced in bronchial epithelium and submucosa in allergic asthma [19] as well as in synovial fluid specimens derived from RA patients [10] . We previously suggested that the TSLP SNPs are associated with susceptibility to allergic rhinitis [20] .
In this study, we analyzed the genotype of TSLP SNPs in RA patients and healthy controls. The genotype and allele frequencies of TSLP SNPs in RA patients were not significantly different from those in the healthy controls group (Table 2 ). This result suggests that the TSLP SNPs not associated with the susceptibility to RA. We also compared the genotype and allele frequencies of the female in RA patients and the healthy controls because of RA more prevail in female. The genotype and allele frequencies of the TSLP SNPs were not associated with the female RA patients (Table 3 ). These results suggest that the TSLP SNPs may be not affected by the gender of RA patients.
The hallmarks of RA are RF and anti-CCP, therefore further evaluation was made to see these SNPs have associations with RF and anti-CCP levels in RA patients. The association levels were measured by ANOVA and compared the relationship. However there are no significant association between the RF and anti-CCP levels and the genotype of TSLP SNPs in RA patients (Table 4 ). These results suggest that the TSLPR SNPs are not affected to RF and anti-CCP levels production in RA patients.
The distribution of the major haplotypes of the TSLP SNPs in the RA patients was not different from the healthy controls (Table 5 ). These results suggest that the haplotypes of the TSLP polymorphisms are not associated with RA susceptibility.
In conclusion, the results of this study suggest that TSLP not associated with the pathogenesis of RA.
